Diabetes care
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.
Shaimaa M Sakr, Shivang Desai, Jose Medina-Inojosa, Chang Liu, Alexander C Razavi, Adithya K Yadalam, Yi-An Ko, Taha Ahmed, Kristen A Harris, Jingwen Huang, Rebecca Yeboah, Nisreen Haroun, Joy D Hartsfield, Muhammad Owais, Rafia Lodhi
Published: 202610.2337/dc25-0940
Abstract
OBJECTIVE: Type 2 diabetes (T2D) is a significant risk factor for adverse outcomes in coronary heart disease (CHD). We investigated whether inflammation and immune dysregulation, measured using soluble urokinase plasminogen activator receptor (suPAR)…
Preview only. Read the full abstract at the source